We wanted to handle the issue of how Grp94 can spread from cancer cells, where it is expressed as tumor antigen, into the circulation, becoming a measurable diagnostic and prognostic tumor biomarker whose expression might also be exploited to predict an immune-modulating activity of therapeutic utility. This evidence concerns the gene HSP90B1 and cancer.